Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Aging

Date Submitted: Jul 10, 2018
Open Peer Review Period: Jul 15, 2018 - Sep 9, 2018
Date Accepted: Jan 23, 2019
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

An Intervention to Promote Medication Understanding and Use Self-Efficacy: Design of Video Narratives for Aging Patients at Risk of Recurrent Stroke

Appalasamy JR, Tha KK, Quek KF, Joseph JP, Seeta Ramaiah S, Md Zain AZ

An Intervention to Promote Medication Understanding and Use Self-Efficacy: Design of Video Narratives for Aging Patients at Risk of Recurrent Stroke

JMIR Aging 2019;2(1):e11539

DOI: 10.2196/11539

PMID: 31518260

PMCID: 6715007

The development and validation of video narratives for aging patients with the risk of recurrent stroke.

  • Jamuna Rani Appalasamy; 
  • Kyi Kyi Tha; 
  • Kia Fatt Quek; 
  • Joyce Pauline Joseph; 
  • Siva Seeta Ramaiah; 
  • Anuar Zaini Md Zain

ABSTRACT

Background:

The debilitating effects of recurrent stroke among aging patients have urged researchers to explore medication adherence among these patients. Video narratives built upon Health Belief Model (HBM) constructs have displayed potential impact on medication adherence adding a plus-point to patient education efforts. However, its effect on medication understanding and use self-efficacy have not been tested.

Objective:

The researchers believed that culturally sensitive video narratives which catered specific niche would reveal a personalized impact on medication adherence. This study aimed to develop and validate video narratives for this purpose.

Methods:

This study adapted Delphi method to develop a consensus on the video scripts contents of learning outcomes and HBM questions. The panel of experts consisted of eight members representing a mix of experiences in stroke in Malaysia. The Delphi method involved three rounds of discussion. Once consensus was achieved, the researchers drafted the initial scripts in English which were then back-translated to the Malay language. Ten bilingual patients within inclusion criteria screened the scripts for comprehension. Subsequently, an actual doctor and patient narrated the scripts while they were filmed; to add the realism of the narratives. Then, the video narratives underwent a few cycles of editing after some feedback on video engagement by the bilingual patients. Few statistical analysis were applied to confirm the validity of the video narratives.

Results:

Initially, the researchers proposed eight learning outcomes and nine HBM questions for the video scripts content. However, following Delphi rounds 1 to 3, few statements were omitted and rephrased. Complete agreement (>80%) arrived for five learning outcomes and five HBM questions. Kendall's coefficient of concordance, W; was above 0.7 which indicated a firm agreement, and SD values within a range of below 1.5 confirmed satisfactory content and construct validity of learning outcomes and HBM questions. Also, the video engagement scores were above average which indicated that the video narratives had a good link with perceived realism.

Conclusions:

The Delphi method was proven to be helpful in conducting discussion systematically and providing precise contents for the development of video narratives. Whereas, the video engagement scale had helped to create realistic video styles and emotions which the researchers believed could positively impact medication understanding and use self-efficacy among patients with stroke. A feasibility and acceptability study in an actual stroke care center is warranted. Clinical Trial: Approvals have been obtained from the Malaysian Medical Research and Ethics Committee – MREC (NMRR ID-15-851-24737) and the Monash University Human Research Ethics Committee - MUHREC (ID 9640), whereas MyStrokeStory trial was registered with the Australian New Zealand Clinical Trials Registry- ANZCTR (ACTRN12618000174280) with Universal Trial Number (UTN) U1111-1201-3955.


 Citation

Please cite as:

Appalasamy JR, Tha KK, Quek KF, Joseph JP, Seeta Ramaiah S, Md Zain AZ

An Intervention to Promote Medication Understanding and Use Self-Efficacy: Design of Video Narratives for Aging Patients at Risk of Recurrent Stroke

JMIR Aging 2019;2(1):e11539

DOI: 10.2196/11539

PMID: 31518260

PMCID: 6715007

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.